BrightSpring Health Services, Inc.

BrightSpring Health Services, Inc. reported strong financial results for the second quarter ended June 30, 2026, with net revenue increasing 23.0% to $3,873 million and Adjusted EBITDA growing 44.2% to $206 million. The company also significantly increased its full-year 2026 guidance for both revenue and Adjusted EBITDA, reflecting confidence in its operational execution. Additionally, BrightSpring completed a $300.0 million debt paydown and repurchased $60.0 million in common stock.

BrightSpring Health Services reported strong second-quarter 2026 financial results, with net revenue increasing 23.0% to $3.87 billion and net income reaching $87 million, a significant rise from $9 million in Q2 2025. The company also announced an increase in its full-year 2026 revenue and Adjusted EBITDA guidance. Key corporate actions included a $300 million debt paydown and a $60 million share repurchase.

BrightSpring Health Services, Inc. announced that it will release its second quarter 2026 financial results on Friday, July 31, 2026. The company will also host an earnings conference call on the same day at 8:30 a.m. ET. Investors can register to participate in the call, and a webcast will be available on the company's investor relations website.

BrightSpring Health Services, Inc. announced the appointment of Dr. Nigam H. Shah to its Board of Directors, increasing the board size from seven to eight members. Dr. Shah, a distinguished Professor at Stanford University and Chief Data Scientist at Stanford Healthcare, brings extensive expertise in information technology and artificial intelligence in healthcare. He will also serve on the Board's Quality and Compliance Committee, with the company anticipating his unique insights will drive clinician and patient success.

BrightSpring Health Services announced the appointment of Dr. Nigam H. Shah as a Class III member of its Board of Directors, effective June 11, 2026. Dr. Shah will also join the Board's Quality and Compliance Committee. He brings extensive experience as Chief Data Scientist at Stanford Healthcare and Associate Dean for Health Information and Data Science, with a focus on integrating AI and technology to enhance patient care and outcomes.

BrightSpring Health Services, Inc. announced the closing of an underwritten offering where selling stockholders, including KKR Phoenix Aggregator L.P. and Management Selling Stockholders, sold 14,999,771 shares of common stock at $58.75 per share. The company did not receive any proceeds from this offering, except for those related to cash exercises of stock options by management. Concurrently, the company repurchased 1,026,465 shares of its common stock from the Underwriter as part of the offering.

BrightSpring Health Services announced the pricing of a previously disclosed underwritten secondary offering by certain selling stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. An aggregate of 15,000,000 shares of common stock are being sold at a public offering price of $58.75 per share, with all proceeds going to the selling stockholders. Concurrently, BrightSpring has authorized the repurchase of 1,026,694 shares from the underwriter at the same price, with no underwriting fees for these shares. The offering is expected to close on June 5, 2026.

BrightSpring Health Services announced that certain stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and members of management, intend to offer 15,000,000 shares of common stock in a secondary offering. The company itself is not selling any shares and will not receive any proceeds from this offering. Concurrently, BrightSpring has authorized the repurchase of shares from the underwriter, up to the lesser of 10% of the shares sold or $60.0 million, with the closing expected to coincide with the offering.

BrightSpring Health Services, Inc. reported a significant increase in net income and revenue for Q1 2026, largely driven by the closing of its Community Living business divestment. The company completed the sale for $810.9 million, realizing a pre-tax gain of $103.4 million. Additionally, BTSG repurchased 1.46 million shares of common stock for $60 million during the quarter.

BrightSpring Health Services, Inc. (BTSG) announced strong financial results for the first quarter ended March 31, 2026, with net revenue increasing 25.6% to $3,614 million and Adjusted EBITDA rising 44.8% to $190 million. The company also raised its full-year 2026 revenue and Adjusted EBITDA guidance, reflecting confidence in continued growth. Additionally, BrightSpring completed the divestiture of its Community Living business and repurchased $60.0 million of common stock during the quarter.